OAM
EW icon

OP Asset Management’s Edwards Lifesciences EW Stock Holding History

OP Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11M Buy
137,471
+463
+0.3% +$38.2K 0.11% 122
2025
Q4 		$11.7M Buy
137,008
+73,240
+115% +$6.01M 0.14% 119
2025
Q3 		$4.96M Buy
63,768
+2,212
+4% +$173K 0.06% 242
2025
Q2 		$4.81M Sell
61,556
-883
-1% -$65.9K 0.07% 229
2025
Q1 		$4.53M Buy
+62,439
New +$4.47M 0.07% 232

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

OP Asset Management's EW Position: Q1 2026 in Review

OP Asset Management increased its Edwards Lifesciences (EW) stake by 0.34% in Q1 2026, buying an estimated $38.2K and bringing the position to 137,471 shares worth $11M. The position accounts for 0.11% of the portfolio, ranked #122.

OP Asset Management first reported a position in EW in Q1 2025 and has held it in 5 quarters since. The position peaked at $11.7M in Q4 2025. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • OP Asset Management held 137,471 shares of Edwards Lifesciences worth $11M as of Q1 2026.
  • OP Asset Management bought 463 Edwards Lifesciences shares in Q1 2026, an estimated $38.2K.
  • Edwards Lifesciences made up 0.11% of OP Asset Management's portfolio in Q1 2026, its #122 holding.
  • OP Asset Management first reported a position in Edwards Lifesciences in Q1 2025 and has held it in 5 quarters since.
  • OP Asset Management's Edwards Lifesciences position peaked at $11.7M in Q4 2025.
  • 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on OP Asset Management's 13F filing for Q1 2026, filed 9 Apr 2026.